C
Chris Smith
Guest
- Researchers from the University of Alabama discovered that a common diabetes drug could significantly reduce the risk of COVID-19 death.
- The scientists do not know how the metformin helps the body fight the novel coronavirus infection but speculate it’s not the drug’s antidiabetic properties at play.
- The researchers say that it might be metformin’s anti-inflammatory and anti-thrombotic properties that are beneficial in COVID-19.
People suffering from various medical conditions are at increased risk of developing life-threatening complications after the infection with the novel coronavirus. Diabetes is one of the main risk factors in COVID-19. That’s why people suffering from the illness are advised to take all the necessary precautions to avoid contracting the virus.
Studying COVID-19 mortality in patients, researchers from the University of Alabama stumbled upon an unexpected finding. One of the common drugs to treat diabetes can reduce the risk of death in COVID-19, a finding that could help doctors save more people who have diabetes who are infected with the coronavirus.
Today's Top Deal
Amazon shoppers can't get enough of these best-selling black masks
Price: $26.25
Buy Now
Continue reading...
Today's Top Deals
- Amazon’s hottest new device is on sale for $12 – and you’ve probably never even heard of it
- These 10 Amazon deals only for Prime members will blow you away
- Amazon is now letting anyone buy these NIOSH N95 masks for $1.16 each
Trending Right Now:
- If you own an iPhone, download and install iOS 14.4 as soon as possible
- This coronavirus drug is 30x more potent than remdesivir, and it works against mutated strains
- Some people who got $600 stimulus checks might not get $1,400 checks
This common diabetes drug might prevent COVID-19 deaths originally appeared on BGR.com on Wed, 27 Jan 2021 at 07:58:18 EDT. Please see our terms for use of feeds.
Via BRG - Boy Genius Report